Risk factors for intestinal colonization with vancomycin resistant enterococci' A prospective study in a level III pediatric intensive care unit
- PMID: 29403213
- PMCID: PMC5784302
- DOI: 10.4103/JLP.JLP_32_17
Risk factors for intestinal colonization with vancomycin resistant enterococci' A prospective study in a level III pediatric intensive care unit
Abstract
Purpose: Vancomycin-resistant enterococci (VRE) emerged as one of the major nosocomial pathogens across the globe. Gut colonization rate with VRE is higher in patients admitted to intensive care units (ICUs) due to the higher antibiotic pressure. VRE colonization increases the risk of developing infection up to 5-10 folds. The aim of this study was to determine the rates of VRE colonization among the patients admitted to pediatric ICU (PICU) and risk factors associated with it.
Materials and methods: Rectal swabs were collected after 48 h of admission to PICU from 198 patients. The samples were inoculated onto bile esculin sodium azide agar with 6 mg/ml of vancomycin. Growth on this medium was identified by the standard biochemical test, and minimum inhibitory concentration of vancomycin and teicoplanin was detected by agar dilution method. Resistance genes for vancomycin were detected by polymerase chain reaction. Risk factors were assessed by logistic regression analysis.
Results: The rates of VRE colonization in patients admitted to PICU was 18.6%. The majority of the isolates were Enterococcus faecium (75.6%) followed by Enterococcus faecalis (24.4%). One patient acquired a VRE bloodstream infection (2.6%) among colonized patients, and none of the noncolonized patients acquired the infection. Consumption of vancomycin was found to be the only risk factor significantly associated with VRE colonization.
Conclusion: Routine surveillance and isolation of patients found to be VRE colonized may not be possible in tertiary care hospitals; however, educating health-care workers, promoting handwashing with antiseptic soaps or solutions, and antibiotic Stewardship policy may help in the reduction of vancomycin resistance and VRE colonization.
Keywords: Enterococcus faecalis; Enterococcus faecium; vancomycin-resistant enterococci; vancomycin-resistant enterococci colonization in Intensive Care Unit.
Conflict of interest statement
There are no conflicts of interest.
Similar articles
-
Screening for Intestinal Colonization with Vancomycin Resistant Enterococci and Associated Risk Factors among Patients Admitted to an Adult Intensive Care Unit of a Large Teaching Hospital.J Clin Diagn Res. 2016 Sep;10(9):DC06-DC09. doi: 10.7860/JCDR/2016/20562.8418. Epub 2016 Sep 1. J Clin Diagn Res. 2016. PMID: 27790430 Free PMC article.
-
Nasal and perirectal colonization of vancomycin sensitive and resistant enterococci in patients of paediatrics ICU (PICU) of tertiary health care facilities.BMC Infect Dis. 2013 Mar 27;13:156. doi: 10.1186/1471-2334-13-156. BMC Infect Dis. 2013. PMID: 23536967 Free PMC article.
-
Prevalence and determinants of fecal colonization with vancomycin-resistant Enterococcus in hospitalized patients in The Netherlands.Infect Control Hosp Epidemiol. 2000 Aug;21(8):520-4. doi: 10.1086/501797. Infect Control Hosp Epidemiol. 2000. PMID: 10968718
-
Vancomycin-resistant enterococci colonization among dialysis patients: a meta-analysis of prevalence, risk factors, and significance.Am J Kidney Dis. 2015 Jan;65(1):88-97. doi: 10.1053/j.ajkd.2014.05.016. Epub 2014 Jul 17. Am J Kidney Dis. 2015. PMID: 25042816
-
Vancomycin-resistant enterococci.Ann Pharmacother. 1996 Jun;30(6):615-24. doi: 10.1177/106002809603000610. Ann Pharmacother. 1996. PMID: 8792949 Review.
Cited by
-
Vancomycin resistant Enterococci and its associated factors among HIV infected patients on anti-retroviral therapy in Ethiopia.PLoS One. 2021 Jun 24;16(6):e0251727. doi: 10.1371/journal.pone.0251727. eCollection 2021. PLoS One. 2021. PMID: 34166383 Free PMC article.
-
Incidence of genes encoding vanA/vanB vancomycin resistance in rectal swabs of patients with diagnosed cancer, on the day of admission to hospital, in a non-epidemic period.Prz Gastroenterol. 2020;15(3):220-224. doi: 10.5114/pg.2020.98537. Epub 2020 Sep 19. Prz Gastroenterol. 2020. PMID: 33005267 Free PMC article.
-
Vancomycin-Resistant Enterococci: Screening Efficacy and the Risk of Bloodstream Infections in a Specialized Healthcare Setting.Antibiotics (Basel). 2025 Mar 16;14(3):304. doi: 10.3390/antibiotics14030304. Antibiotics (Basel). 2025. PMID: 40149114 Free PMC article.
-
Microbial spectrum and drug resistance of pathogens cultured from gallbladder bile specimens of patients with cholelithiasis: A single-center retrospective study.World J Gastrointest Surg. 2022 Dec 27;14(12):1340-1349. doi: 10.4240/wjgs.v14.i12.1340. World J Gastrointest Surg. 2022. PMID: 36632118 Free PMC article.
-
Gut colonization with vancomycin-resistant Enterococcus and risk for subsequent enteric infection.Gut Pathog. 2018 Jul 9;10:28. doi: 10.1186/s13099-018-0259-4. eCollection 2018. Gut Pathog. 2018. PMID: 30002733 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases